4-butyrolactone has been researched along with andrographolide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chatterjee, M; Chowdhury, C; Das, B; Das, P; Kumar, D; Roy, R; Sen, R | 1 |
| Chen, D; Lu, Y; Song, Y; Xue, X | 1 |
| Lajis, NH; Phillips, R; Sagineedu, SR; Sidik, SM; Stanslas, J; Sumon, SH; Wong, CC | 1 |
3 other study(ies) available for 4-butyrolactone and andrographolide
| Article | Year |
|---|---|
Synthesis, cytotoxicity, and structure-activity relationship (SAR) studies of andrographolide analogues as anti-cancer agent.
Topics: 4-Butyrolactone; Antineoplastic Agents; Cell Line, Tumor; Diterpenes; Drug Screening Assays, Antitumor; Humans; Leukemia; Molecular Structure; Spectrum Analysis; Structure-Activity Relationship | 2010 |
Synthesis and in vitro cytotoxicity of andrographolide-19-oic acid analogues as anti-cancer agents.
Topics: 4-Butyrolactone; Antineoplastic Agents; Cell Proliferation; Diterpenes; Drug Screening Assays, Antitumor; Esterification; HCT116 Cells; Humans; MCF-7 Cells; Oxidation-Reduction; Structure-Activity Relationship | 2013 |
NCI in vitro and in silico anticancer screen, cell cycle pertubation and apoptosis-inducing potential of new acylated, benzylidene and isopropylidene derivatives of andrographolide.
Topics: 4-Butyrolactone; Antineoplastic Agents; Apoptosis; Benzylidene Compounds; BH3 Interacting Domain Death Agonist Protein; Caspase 8; Cell Cycle; Cell Line, Tumor; Cell Survival; Diterpenes; Drug Screening Assays, Antitumor; HCT116 Cells; Heterocyclic Compounds, 3-Ring; Humans; In Vitro Techniques; MCF-7 Cells; Models, Molecular; National Cancer Institute (U.S.); Neoplasms; Signal Transduction; United States | 2014 |